Jonathan Peacock

Jonathan Peacock

Président chez UCB

Fortune : 2 M $ au 31/05/2026

68 ans
Health Technology
Commercial Services
Consumer Services

Profil

Jonathan M.
Peacock
was the founder of Arix Bioscience, founded in 2015, where the title held was Non-Executive Director in 2020.
Current jobs include Chairman at UCB SA since 2023, Chairman at BlueSphere Bio, Inc. since 2021, Director at Real Chemistry, Inc. since 2019, Director at Natural History Museum of Los Angeles County, Trustee at Los Angeles County Museum of Natural History, and Vice Chancellor-Health Sciences at the University of California San Diego.
Former jobs include Chairman at Bellerophon Therapeutics, Inc. from 2016 to 2021, Independent Chairman at Avantor, Inc. from 2022 to 2025, Director at Onyx Pharmaceuticals, Inc., Independent Director at Genmab A from 2020 to 2021, Independent Director at Kite Pharma, Inc. from 2014 to 2017, Director at Socati Corp.
from 2019 to 2020, Chief Financial Officer & Executive Vice President at Amgen, Inc. from 2010 to 2014, Partner at PricewaterhouseCoopers LLP from 1993 to 1998, Chief Financial & Administrative Officer at Novartis AG from 2005 to 2010, Partner at McKinsey & Co., Inc. from 1998 to 2005, Chief Financial Officer at Amgen Ventures LLC, Partner at PricewaterhouseCoopers LLP (United Kingdom) from 1993 to 1998, Chief Financial Officer & Executive Vice President at Amgen Rockville, Inc. in 2012, and Chief Financial & Administrative Officer at Novartis Pharmaceuticals AG from 2005 to 2010.
Education includes graduation from the University of St. Andrews in 1981.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
08/05/2025 219 815 ( 0,03 % ) 2 M $ 31/05/2026

Postes actifs de Jonathan Peacock

SociétésPosteDébut
UCB Président 09/03/2023
Président 19/08/2021
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/11/2019
Directeur/Membre du Conseil -
Corporate Officer/Principal -

Anciens postes connus de Jonathan Peacock

SociétésPosteFin
AVANTOR, INC. Président 31/12/2025
GENMAB A/S Directeur/Membre du Conseil 15/11/2021
BELLEROPHON THERAPEUTICS, INC. Directeur Général 11/11/2016
░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Jonathan Peacock

Formation de Jonathan Peacock

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

87

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées22

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Commercial Services

Health Technology

Consumer Services

Health Technology

Commercial Services

Novartis Pharmaceuticals AG

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

  1. Bourse
  2. Insiders
  3. Jonathan Peacock
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇